Create Account

One Health helps you track and understand your health simply.

Create Account

One Health helps you track and understand your health simply.

In vitro bleeding time with epinephrine (preliminary)

Immunology & Autoimmune

BT-EPIIn vitro bleeding time with epinephrinePFA-100 collagen/epinephrine closure timePFA EPI CT

Review status

Currently under review

Pending specialist review and validation.

What it shows

This test estimates how effectively your platelets form a plug to stop bleeding by measuring the time it takes blood to close a tiny opening inside a cartridge coated with collagen and epinephrine. It is a laboratory, in vitro version of a bleeding time assessment, performed under standardized flow conditions.

It serves as a screening check of platelet function and the interaction between platelets and von Willebrand factor. Because it is labeled preliminary, results are used to guide whether additional tests, such as a companion cartridge or more specialized platelet or von Willebrand studies, are needed.

Why it matters

Your clinician may order this test if you bruise easily, have frequent nosebleeds, heavy menstrual bleeding, or unexpected bleeding after dental work or surgery, or to evaluate the effect of antiplatelet medicines. It helps identify when platelet function may be impaired and can support decisions about timing of procedures or medication adjustments.

The result can be influenced by common medicines and several health conditions, so it is not a stand‑alone diagnosis. Abnormal findings usually lead to targeted follow‑up, such as a von Willebrand disease panel, a second cartridge test, or formal platelet function testing, to clarify the cause and guide care.

Understanding your results

A result within the expected range suggests that, under the test conditions, your platelets are forming a plug as anticipated. This does not rule out all bleeding disorders, and your overall history still matters. If your result is slower than expected, common reasons include recent aspirin or certain pain relievers, an inherited or acquired platelet problem, von Willebrand disease, or changes in blood counts.

If your result is outside the expected range, your clinician may review your medicines, consider repeating the test after avoiding interfering drugs when safe, and order additional studies such as a von Willebrand panel, a companion cartridge test, a platelet count, and other assessments. Talk with your care team about symptoms, procedure plans, and the safest next steps for you.

Reference ranges

75170 s
All sexes
0 days – 150 years

Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.

Factors that could impact In vitro bleeding time with epinephrine (preliminary)

  • Antiplatelet and pain medications

    Aspirin, many NSAIDs, and drugs like clopidogrel or ticagrelor can slow platelet plug formation and prolong the result. Always tell your clinician and lab about everything you take, including over‑the‑counter products.

  • Sample timing and handling

    This test uses citrated whole blood and is sensitive to delays, temperature, and agitation. Improper transport or testing too long after collection can artifactually prolong the result.

  • Platelet count and hematocrit

    Low platelet count or low red cell concentration can lengthen the closure time even if intrinsic platelet function is normal. Your clinician will usually interpret results alongside a complete blood count.

  • Von Willebrand factor fluctuations

    Von Willebrand factor can rise with stress, inflammation, infection, or pregnancy and can fall with certain conditions. These shifts may normalize or alter a borderline abnormal screen.

  • Diet, alcohol, and supplements

    Recent alcohol intake and some supplements, such as fish oil or high‑dose garlic, may affect platelet function. Share details about supplements and recent intake with your care team.

  • Recent procedures and lifestyle

    Strenuous exercise, smoking, or acute illness around the time of testing can influence results. Scheduling when you are well and following pretest instructions improves reliability.

2026

References

  1. McGill University Health Centre. (2017, March 30). Invitro BT avec EPI Preliminary (Task CD 18477606). Laboratory reference ranges.
  2. Clinical and Laboratory Standards Institute. (2008). Platelet Function Analyzer (PFA-100) testing; Approved guideline (CLSI document H58-A). Wayne, PA: CLSI.
  3. Connell, N. T., Flood, V. H., Brignardello-Petersen, R., et al. (2021). ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease. Blood Advances.